QEDIT

Secure Data Collaboration Platform for Enterprises

Cyber Security
Private

Company Overview

Snapshot

Founded in January 2016 by Jonathan Rouach and Aviv Zohar, QEDIT operates with 1–10 employees. The company has raised $12.5 million across 2 funding rounds from 13 investors. In May 2019, QEDIT secured funding from investors including MizMaa Ventures and RGAX.

Business overview

QEDIT provides a secure data collaboration platform for enterprises, leveraging privacy-enhancing technologies to enable safe data exchange and analysis without exposing underlying sensitive information. The company's ISO 20071-certified platform ensures compliance with regulations like GDPR and CCPA, serving various sectors including banking, insurance, and eCommerce. Its technology is applied to detect fraud, mitigate financial crime, verify identities, reveal industry benchmarks, and enrich customer profiles.

Strategic signal

This signifies a strong validation of QEDIT's core technology and its potential for high-impact applications beyond commercial use, positioning the company as a key player in advanced cryptographic research and development.

Company Intelligence Q&A

What is QEDIT's primary focus?
QEDIT focuses on secure data collaboration for enterprises, utilizing privacy-enhancing technologies to enable safe data exchange and analysis without exposing underlying data.
When was QEDIT founded and by whom?
QEDIT was founded in January 2016 by Jonathan Rouach and Aviv Zohar.
Which organizations have partnered with QEDIT?
QEDIT has partnered with cross-industry market leaders including VMware, Ant Financial, RGAX, Deloitte, and Samsung SDS to deploy its solutions.
What significant recognition has QEDIT received?
QEDIT was recognized as a World Economic Forum Technology Pioneer for its contributions to data privacy and was selected to join a Defense Advanced Research Projects Agency (DARPA) research project.
What was a key funding event for QEDIT?
In May 2019, QEDIT secured funding from investors including MizMaa Ventures and RGAX.